Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
STLN · NASDAQ · Services-Offices & Clinics Of Doctors Of Medicine
Starling Oncology (STLN) · oqro.io/stocks/STLN · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$3.50−0.25 (−6.67%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Including 5 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Insider filing
Traded Nov 11 · filed 3 days later
Not classified as an open-market trade.
Insider buying
First insider buy since Mar 2025Traded Nov 9 · filed 1 day later
Since the trade −12.5% · S&P 500 +0.2% · to Nov 13
A major shareholder of Starling Oncology paid $176K out of pocket for Starling Oncology shares. It was the first purchase in over a year.
Insider selling
Traded Nov 6 · filed 4 days laterNot reported under a pre-arranged trading plan
Since the trade −3.3% · S&P 500 +2.6% · to Nov 13
A major shareholder of Starling Oncology sold $11.4M of Starling Oncology shares. The filing does not indicate a pre-arranged trading plan.
Traded Nov 6 – Nov 10, 2026 · largest single transaction ~$4.7K
Nov 6, 202610K · @ $0.075
DetailsOfficial recordTraded Sep 4, 2025 · largest single transaction ~$18.6MNot reported under a pre-arranged trading plan
Sep 4, 2025~$18.6M · 6.02M sh @ $3.09
DetailsInsider selling
Traded Aug 19, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
A Starling Oncology director sold $82K of Starling Oncology shares. The filing does not indicate a pre-arranged trading plan.
Traded Jun 5, 2025 · largest single transaction ~$2.05MNot reported under a pre-arranged trading plan
Jun 5, 2025~$2.05M · 674K sh @ $3.05
DetailsInsider selling
Traded Jun 3, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
A Starling Oncology director sold $5.36M of Starling Oncology shares. The filing does not indicate a pre-arranged trading plan.
Brad Hively (Director) sold ~$312K of Starling Oncology
Automatic saleTraded May 20, 2025 · largest single transaction ~$4.87MNot reported under a pre-arranged trading plan
May 20, 2025~$4.87M · 1.8M sh @ $2.71
DetailsInsider buying
Traded Mar 26, 2025 · filed 33 days later
A Starling Oncology director paid $47K out of pocket for Starling Oncology shares. 7 other people at Starling Oncology bought some too, in the same month. Shares held went up 7% with this purchase.
Insider buying
Traded Mar 26, 2025 · filed 2 days later
A Starling Oncology director paid $1.42M out of pocket for Starling Oncology shares. 7 other people at Starling Oncology bought some too, in the same month. Shares held went up 326% with this purchase.
Insider buying
Traded Mar 26, 2025 · filed 2 days later
A Starling Oncology director paid $94K out of pocket for Starling Oncology shares. 7 other people at Starling Oncology bought some too, in the same month. Shares held went up 67% with this purchase.
Insider buying
Traded Mar 26, 2025 · filed 2 days later
A Starling Oncology director paid $38K out of pocket for Starling Oncology shares. 7 other people at Starling Oncology bought some too, in the same month. Shares held went up 22% with this purchase.
Insider buying
Traded Mar 26, 2025 · filed 2 days later
The CFO of Starling Oncology paid $9.4K out of pocket for Starling Oncology shares. 7 other people at Starling Oncology bought some too, in the same month. Shares held went up 30% with this purchase.
Insider buying
Traded Mar 26, 2025 · filed 2 days later
The CEO of Starling Oncology paid $24K out of pocket for Starling Oncology shares. 7 other people at Starling Oncology bought some too, in the same month.
Insider buying
Traded Mar 26, 2025 · filed 2 days later
Starling Oncology's Chief Medical Officer paid $9.4K out of pocket for Starling Oncology shares. 7 other people at Starling Oncology bought some too, in the same month. Shares held went up 13% with this purchase.
Insider buying
Traded Mar 26, 2025 · filed 2 days later
Starling Oncology's Chief Operating Officer paid $9.4K out of pocket for Starling Oncology shares. 7 other people at Starling Oncology bought some too, in the same month. Shares held went up 11% with this purchase.
Traded Nov 26 – Dec 2, 2024 · largest single transaction ~$43K
Nov 26, 2024~$43K · 250K sh @ $0.17
DetailsOfficial recordNov 6, 20265,000 · @ $0.40
Nov 9, 20267,500 · @ $0.5357
DetailsOfficial recordNov 10, 20267,000 · @ $0.67
DetailsOfficial recordSep 4, 2025~$2.11M · 682K sh @ $3.09
DetailsOfficial recordJun 5, 2025~$233K · 76K sh @ $3.05
DetailsOfficial recordMay 20, 2025~$552K · 204K sh @ $2.71
DetailsOfficial recordDec 2, 2024~$7.5K · 50K sh @ $0.15
DetailsOfficial record1 open-market purchase and 1 open-market sale by insiders of STLN between Feb 10, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 5, 2026. The data provider lists the next release for Mar 10, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 5, 2026 | None | None | 1 purchase, 1 sale |
| Aug 6, 2026 | None | None | None |
| May 7, 2026 | None | None | None |
| Mar 12, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies